Incidence of distal intestinal obstruction syndrome in cystic fibrosis

Beryl J Rosenstein, Terry S. Langbaum

Research output: Contribution to journalArticle

Abstract

A variety of intestinal complications, includ-ing constipation, abdominal pain, palpable cecal masses, intestinal obstruction, intussusception, and volvulus, have been observed beyond the neonatal period in patients with cystic fibrosis (CF). In a retrospective chart review of 63 patients with CF, we found evidence of one or more of these complications in 26 patients (41.3%). The incidence of intestinal complications was not related to overall disease severity, pulmonary exacerbations, history of meconium ileus at birth, or dose or type of pancreatic enzyme replacement. There was no change in the incidence of intestinal complications after patients switched to a pH-sensitive enteric-coated microsphere enzyme preparation.

Original languageEnglish (US)
Pages (from-to)299-301
Number of pages3
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume2
Issue number2
StatePublished - 1983

Fingerprint

Intestinal Obstruction
cystic fibrosis
intestinal obstruction
Cystic Fibrosis
incidence
Incidence
volvulus
Intestinal Volvulus
Meconium
constipation
Intussusception
Ileus
Enzymes
Constipation
enzymes
Microspheres
disease severity
Abdominal Pain
Lung Diseases
pain

Keywords

  • Cystic fibrosis
  • Distal intestinal obstruction syndrome
  • Pancreatic enzyme replacement

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health
  • Food Science
  • Medicine (miscellaneous)
  • Histology

Cite this

Incidence of distal intestinal obstruction syndrome in cystic fibrosis. / Rosenstein, Beryl J; Langbaum, Terry S.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 2, No. 2, 1983, p. 299-301.

Research output: Contribution to journalArticle

@article{939bd4d665de47d4a3bbe1e233746fbe,
title = "Incidence of distal intestinal obstruction syndrome in cystic fibrosis",
abstract = "A variety of intestinal complications, includ-ing constipation, abdominal pain, palpable cecal masses, intestinal obstruction, intussusception, and volvulus, have been observed beyond the neonatal period in patients with cystic fibrosis (CF). In a retrospective chart review of 63 patients with CF, we found evidence of one or more of these complications in 26 patients (41.3{\%}). The incidence of intestinal complications was not related to overall disease severity, pulmonary exacerbations, history of meconium ileus at birth, or dose or type of pancreatic enzyme replacement. There was no change in the incidence of intestinal complications after patients switched to a pH-sensitive enteric-coated microsphere enzyme preparation.",
keywords = "Cystic fibrosis, Distal intestinal obstruction syndrome, Pancreatic enzyme replacement",
author = "Rosenstein, {Beryl J} and Langbaum, {Terry S.}",
year = "1983",
language = "English (US)",
volume = "2",
pages = "299--301",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Incidence of distal intestinal obstruction syndrome in cystic fibrosis

AU - Rosenstein, Beryl J

AU - Langbaum, Terry S.

PY - 1983

Y1 - 1983

N2 - A variety of intestinal complications, includ-ing constipation, abdominal pain, palpable cecal masses, intestinal obstruction, intussusception, and volvulus, have been observed beyond the neonatal period in patients with cystic fibrosis (CF). In a retrospective chart review of 63 patients with CF, we found evidence of one or more of these complications in 26 patients (41.3%). The incidence of intestinal complications was not related to overall disease severity, pulmonary exacerbations, history of meconium ileus at birth, or dose or type of pancreatic enzyme replacement. There was no change in the incidence of intestinal complications after patients switched to a pH-sensitive enteric-coated microsphere enzyme preparation.

AB - A variety of intestinal complications, includ-ing constipation, abdominal pain, palpable cecal masses, intestinal obstruction, intussusception, and volvulus, have been observed beyond the neonatal period in patients with cystic fibrosis (CF). In a retrospective chart review of 63 patients with CF, we found evidence of one or more of these complications in 26 patients (41.3%). The incidence of intestinal complications was not related to overall disease severity, pulmonary exacerbations, history of meconium ileus at birth, or dose or type of pancreatic enzyme replacement. There was no change in the incidence of intestinal complications after patients switched to a pH-sensitive enteric-coated microsphere enzyme preparation.

KW - Cystic fibrosis

KW - Distal intestinal obstruction syndrome

KW - Pancreatic enzyme replacement

UR - http://www.scopus.com/inward/record.url?scp=0020531624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020531624&partnerID=8YFLogxK

M3 - Article

C2 - 6553601

AN - SCOPUS:0020531624

VL - 2

SP - 299

EP - 301

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -